Buch, Englisch, 314 Seiten, Format (B × H): 159 mm x 241 mm, Gewicht: 1260 g
Buch, Englisch, 314 Seiten, Format (B × H): 159 mm x 241 mm, Gewicht: 1260 g
ISBN: 978-0-12-800186-8
Verlag: Elsevier Science
Aimed at "drug discoverers" - i.e. any scientist who is interested in neurodegenerative diseases in general, and in finding disease-modifying treatments in particular - the first edition of Molecular Targets in Protein Misfolding and Neurodegenerative Disease will contain both a detailed, discipline-specific coverage (paragraphs on medicinal chemistry, on clinical and preclinical characterization of compounds in development, on target identification and validation, on genetic factors influencing a pathology, etc.) and a drug discovery-oriented, overall evaluation of each target (validation, druggability, existing leads, etc.). Together these will satisfy the needs of various audiences, including in vitro biologists, pharmacologists, medicinal chemists, etc.
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Alzheimer und Demenz
Weitere Infos & Material
1. Protein misfolding, neurodegeneration and Tau: The main players, or the usual suspects?2. Targeting the protein quality control (PQC) machinery: The neuronal Salvation Army3. Proteasomal degradation of soluble, misfolded proteins: Throwing out the bath water, but where's the baby?4. Unselective disposal of cellular aggregates: Engulf, devour and digest to recycle5. Selective disposal of insoluble protein aggregates: Pick, transport and remove to cure6. Assembly and disassembly of protein aggregates: Unraveling the maze
